Advertisement

Cefazolin Injection

[25 June 2015]

Products Affected - Description

Cefazolin intravenous powder for solution for injection, Fresenius Kabi
10 gram, 1 count (NDC 63323-0238-61)
20 gram, 1 count (NDC 63323-0446-66)

Cefazolin intravenous injection, BBraun
1 gram/50 mL premix, 1 count (NDC 00264-3103-11)
2 gram/50 mL premix, 1 count (NDC 00264-3105-11)
 
Cefazolin intravenous powder for solution for injection, Hospira
10 gram, 10 count (NDC 00409-0806-01)
 
Cefazolin intravenous powder for solution for injection, Sagent
10 gram, 1 count (NDC 25021-0102-99) 
 
Cefazolin intravenous powder for solution for injection, WG Critical Care
20 gram, 10 count (NDC 44567-0709-10) - discontinued

Reason for the Shortage

  • BBraun has cefazolin on shortage due to increased demand.
  • Fresenius Kabi has cefazolin on shortage due to increased demand.
  • WG Critical Care has cefazolin on shortage due to increased demand. WG Critical Care discontinued cefazolin 20 gram to focus on other strengths.
  • Sandoz has cefazolin on shortage due to manufacturing delays.
  • Hospira has cefazolin on shortage due to increased demand.
  • Sagent has cefazolin on shortage due to increased demand.

Available Products

Cefazolin intravenous powder for solution for injection, Apotex
1 gram, 25 count (NDC 60505-0749-05)
10 gram, 1 count (NDC 60505-0769-00)
 
Cefazolin intravenous injection, Baxter
1 gram/ 50 mL premix, 24 count (NDC 00338-3503-41)
 
Cefazolin intravenous powder for solution for injection, Fresenius Kabi
500 mg, 1 count (NDC 63323-0236-10)
1 gram, 25 count (NDC 63323-0237-10)
 
Cefazolin intravenous powder for solution for injection, Hospira
1 gram, 25 count (NDC 00409-0805-01)
1 gram, Add-Vantage vial, 25 count (NDC 00409-2585-01)
 
Cefazolin intravenous powder for solution for injection, Sagent
500 mg, 25 count (NDC 25021-0100-10)
1 gram, 25 count (NDC 25021-0101-10)
 
Cefazolin intravenous powder for solution for injection, Samson Medical Technologies
100 gram SmartPak bulk package (NDC 66288-1100-01)
300 gram SmartPak bulk package (NDC 66288-1300-01)
 
Cefazolin intravenous powder for solution for injection, Sandoz
500 mg, 10 count (NDC 00781-3450-95)
1 gram, 25 count, (NDC 00781-3451-96)
10 gram, 10 count (NDC 00781-3452-95)
 
Cefazolin intravenous powder for solution for injection, WG Critical Care
500 mg, 25 count (NDC 44567-0706-25)
1 gram, 25 count (NDC 44567-0707-25)
10 gram, vial, 10 count (NDC 44567-0708-10)
 
Cefazolin intravenous powder for solution for injection, West-Ward
500 mg, 25 count (NDC 00143-9923-90)
1 gram, 25 count (NDC 00143-9924-90)
10 gram, 10 count (NDC 00143-9983-03)

Estimated Resupply Dates

  • Fresenius Kabi has cefazolin 10 gram and 20 gram vials on back order and the company estimates a release date of late-July 2015. 
  • BBraun has cefazolin 1 gram/50 mL and 2 gram/50 mL premixes on allocation for contracted customers.
  • Hospira has cefazolin 10 gram vials available in limited supply and for direct order only.
  • Sagent has cefazolin 10 gram vials on allocation

Related Shortages

Updated

June 11 and 25, May 12, 13, 21, and 28, April 2, 17, and 29, March 10, February 5 and 20, January 9 and 20, 2015; December 5, 12, and 22, November 6, 11, 20, and 21, October 1 and 16, September 4, 18, and 26, August 21, July 18, June 13 and 26, May 8, 12, and 28, April 2, 15, and 30, March 5, 18, and 25, February 10 and 19, January 6, 21, 24, and 29, 2014; December 3 and 19, November 13, October 10, 21, and 30, September 3 and 23, August 1, 13, and 27, July 3 and 18, June 6, May 6 and 30, April 1 and 12, March 7 and 29, February 5 and 12, January 10 and 23, 2013, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement